Search Results

Your search for Manali I. Patel, MD, MPH, MS matches 2 pages

Showing 1 - 2

By Manali I. Patel, MD, MPH, MS / May 25, 2022

Long-Term Overall Survival in Unresectable Stage III NSCLC With Consolidation Durvalumab in the PACIFIC Trial: Translation to Real-World Outcomes?

Lung cancer mortality rates have declined by more than 50% in men since 1990 and more than 30% in women since 2002. These declines in mortality are largely due to increases in smoking cessation. However, in recent years, clinical treatment advances, such as targeted therapies and immunotherapy,...

By ASCO / April 10, 2016

Conquer Cancer Foundation Honors 74 Oncologists for Contributions to Genitourinary Cancer, Cancer Survivorship, Gastrointestinal Cancer, and Quality Care Research

The Conquer Cancer Foundation of ASCO is pleased to announce the recipients of its 2016 Conquer Cancer Foundation of ASCO Merit Awards in Gastrointestinal Cancer, Genitourinary Cancer, Cancer Survivorship, and Quality Care. The following 74 young investigators, recognized for the scientific merit...

Jul

Today In Oncology

Search Results

Your search for Manali I. Patel, MD, MPH, MS matches 2 pages

Long-Term Overall Survival in Unresectable Stage III NSCLC With Consolidation Durvalumab in the PACIFIC Trial: Translation to Real-World Outcomes?

Conquer Cancer Foundation Honors 74 Oncologists for Contributions to Genitourinary Cancer, Cancer Survivorship, Gastrointestinal Cancer, and Quality Care Research

In Metastatic RAS Wild-Type Left-Sided Colorectal Cancer, Panitumumab Proves Superior to Bevacizumab

EPOV Chiara Cremolini

Food Interventions and Cancer Treatment Completion Rates Among Food-Insecure Patients in New York City

Screening Study to Identify Risk Factors for Breast Cancer–Related Lymphedema

FDA Warns About Possible Increased Risk of Death and Serious Side Effects With Duvelisib